Qiagen
QIAGEN N.V., a Netherlands -based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics support the interpretation of complex data to deliver actionable insights. Automation solutions integrate these steps into streamlined, cost-effective workflows. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences (academia, pharmaceutical R&D and industrial applications such as forensics) and Molecular Diagnostics (clinical healthcare). As of September 30, 2026, QIAGEN employed about 5,400 people across more than 35 locations.
What If You Bought QGEN Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jan 29, 2025 | $45.14 | 36-for-35 | 1.0285714285714285× | 8.228571428571428× |
| Jul 14, 2000 | — | 4-for-1 | 4× | 8× |
| Jul 16, 1999 | — | 2-for-1 | 2× | 2× |
Qiagen Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 3 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.